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Abstract
Recent seminal studies have rapidly advanced the understanding of intestinal epithelial stem cell
(IESC) biology in murine models. However, the lack of techniques suitable for isolation and
subsequent downstream analysis of IESCs from human tissue has hindered the application of these
findings toward the development of novel diagnostics and therapies with direct clinical relevance.
This study demonstrates that the cluster of differentiation genes CD24 and CD44 are differentially
expressed across LGR5 positive “active” stem cells as well as HOPX positive “facultative” stem
cells. Fluorescence-activated cell sorting enables differential enrichment of LGR5 cells (CD24−/
CD44+) and HOPX (CD24+/CD44+) cells for gene expression analysis and culture. These
findings provide the fundamental methodology and basic cell surface signature necessary for
isolating and studying intestinal stem cell populations in human physiology and disease.
Introduction
Lgr5 was the first validated IESC biomarker shown to be expressed in actively cycling
mouse crypt base columnar cells (CBCs) 1. Subsequent studies demonstrated a secondary,
“reserve” population of mouse IESCs marked by Bmi1, Hopx, mTert, and Lrig 2–5.
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Emerging evidence indicates overlapping expression of Lgr5 with these “reserve” IESC
biomarkers; however, Lgr5-negative cell populations have also been shown to
dedifferentiate in response to damage, suggesting the existence of one or more functionally
competent ‘facultative’ IESC populations 6–8. Despite these advances in IESC biomarker
discovery, FACS isolation and functional characterization of putative ‘“active” and “reserve/
facultative” IESC populations from human intestinal tissue has been limited by the lack of
validated human IESC biomarkers and in vitro assays to functionally test stemness at the
single cell level.
Investigators in other stem cell fields have utilized FACS-based approaches, which rely on
multiple cell surface antigens, to isolate target stem cell populations of varying purity.
Notably, biomarkers comprised of cluster-of-differentiation (CD) genes have long been used
to identify hematopoietic stem cells and their progenitors 9. We recently adopted a similar
strategy to demonstrate that low levels of CD24 facilitate FACS of Sox9Low/Lgr5+ murine
IESCs capable of forming enteroids in vitro 10. Similarly, CD44 is expressed in the stem cell
zone of the murine small intestine and can be used to enrich for Lgr5+ CBCs (Magness et al,
unpublished). In this study we explored whether CD24 and CD44 could be used to FACS-
isolate human IESCs.
Methods
Patients/Tissue collection and preparation
De-identified tissue from female patients ranging between 33–53 yrs of age with body mass
indices of 39–60 kg/m2 was used in this study. Tissue was obtained from laparoscopic roux-
en-y gastric bypass surgery and represents jejunal segments of approximately 4 cm in
length. Following resection, tissue was placed in a specimen cup on ice until a mucosectomy
was performed, aided by injecting ice-cold saline between the mucosa and submucosa prior
to careful dissection. Single cell dissociation was carried out on a small portion of the total
mucosa (1 cm × 1 cm) for gene expression studies and a larger tissue area (4cm × 4cm) was
dissociated for culture experiments. For an informative comparison, the mass of mucosa
used for this preparation represents approximately 300- and 1200-times the mucosal mass of
an average biopsy from endoscopy or colonoscopy at UNC (13 mg/biopsy; unpublished,
Drs. Tope Keku/Robert Sandler), respectively. Following dissection, mucosa was placed in
3 mM EDTA in 1x PBS for 45 min at 4°C on a rocker to remove villi. The villus fraction
was discarded (Supplemental Figure 1A) and the remaining mucosa was then transferred
into 5 mL of PBS and lightly shaken by hand (approximately 1 shake/sec for 2 min) to
remove the remaining epithelium (Supplemental Figure 1B). An equal volume of 2%
Sorbitol made in 1x PBS (Sigma, St. Louis, MO) was added. To further deplete the solution
of contaminating villi, the epithelial solution was passed through a 70μm filter. This
procedure results in a ‘crypt-enriched’ epithelial preparation (Supplemental Figure 1C). The
crypts were pelleted at 150x g for 10 min at 4°C. Crypts were then digested to single cells
by resuspending the pellet in 5 mL of HBSS containing 0.3 U/mL of dispase (Worthington
Biochemical, Lakewood, NJ) followed by incubation at 37°C for 10 min. The crypt solution
was then manually shaken for 30 sec (3–4 shakes/sec). The solution was then checked for
extent of dissociation to single cells. If cell clumps remained, shaking cycle was repeated
every 5 minutes, then checked for extent of dissociation. Shaking cycles were stopped at the
earliest time point at which 80–90% of crypts were dissociated to completion or up to 30
min maximum. An average of 1 × 107 cells was obtained from a 1 cm × 1 cm mucosal
segment. Single cells were filtered using a 40μm filter to remove undissociated clumps. For
FACS, 1 × 107 cells were placed in 500μL of IESC staining media (see Flow cytometry
section, below) for antibody staining. Human tissue used in this study was deemed exempt
from full Institutional Review Board review (approval #09-2159).
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A 3 cm square piece of jejunum from each case was fixed with freshly made 4%
paraformaldehyde (PFA) for a 24–48h at 4°C. The tissues were then prepared for
cryosectioning by immersion in 30% sucrose for at least 24h at 4°C. Tissues were embedded
in Tissue-Tek optimal cutting temperature (OCT) medium (Sakura, Torrance, CA) and
frozen on dry ice. 8–10μm sections were cut on a cryostat and placed on positively charged
microscope slides. Prior to immunostaining, tissue sections were rinsed twice in PBS to
remove OCT. Non-specific binding was blocked by applying Dako Protein Block (Dako,
Carpinteria, CA, X0909) to tissue sections for 30 min at room temperature. Primary
antibodies were applied in Dako Antibody Diluent (Dako, S0809) and incubated for 2h at
room temperature. Dilutions were as follows: CD326/EpCAM (1:250, clone 9C4,
BioLegend, San Diego, CA), CD44 (1:250, clone IM7, BioLegend), CD24 (1:100, clone
ML5, Biolegend), Lysozyme (1:500, Diagnostic Biosystems, Pleasanton, CA), Mucin2
(1:100, Santa Cruz Biotechnology, Santa Cruz, CA), Sucrase Isomaltase A-17 (1:100, Santa
Cruz), ChromograninA (1:500, Immunostar, Hudson, WI). Anti-Rabbit-Cy3 (1:500 Sigma,
St. Louis, MO, C2306) and anti-Rat-Cy3 (1:500 Jackson Immunoresearch, Carlsbad, CA,
112-165-003) secondary detection antibodies were diluted in Dako Antibody Diluent and
applied to tissue for 30 min at room temperature. Nuclei were stained for 10 minutes with
bisbenzamide (1:1,000, Sigma) diluted in PBS. Background staining was negligible as
determined by nonspecific IgG staining. Images were collected by capturing ~1 μm optical
sections using a Zeiss LSM 710 confocal microscope.
Flow Cytometry/FACS
Cells were stained for 90 min on ice in IESC Staining Media [Advanced DMEM/F12
(Gibco), N2 (Gibco), B27 (Gibco), Glutamax (Gibco), Penicillin/Streptomycin (Gibco),
10μM Y27632 (Selleck Chemicals, Houston, TX), 500mM N-acetyl-cysteine (Sigma), and
10% FBS (Gemini Biosciences)] with the following antibodies or isotype controls:
AlexaFluor 647 (Alexa647) conjugated anti-CD24 [1:100] (clone ML5, Biolegend #311109,
San Diego, CA), Pycoerythrin-Cy7 (PE-Cy7) conjugated anti-CD45 [1.6:100] (Biolegend
#304015), Fluorescein isothiocyanate (FITC) conjugated anti-EpCAM [4:100](clone 9C4,
Biolegend #324203), and Brilliant Violet 421 (BV421) conjugated anti-CD44 [0.6:100]
(clone IM7, Biolegend #103039). For initial analysis by flow cytometry, 1 ×106 cells were
stained, fixed in 2% PFA for 10 min at room temperature, then rinsed (with PBS) and
resupended in 500 μL of PBS for analysis using a Beckman-Coulter (Dako) CyAn ADP
(Supplemental Figure 2). For sorting experiments, cells were rinsed and resuspended in
IESC Sort/Culture Media [Advanced DMEM/F12 (Gibco), N2 (Gibco), B27 (Gibco),
Glutamax (Gibco), Penicillin/Streptomycin (Gibco), 10mM HEPES (Gibco), 10μM Y27632
(Selleck Chemicals), and 500mM N-acetyl-cysteine (Sigma)]. FACS was conducted using
an iCyt Reflection (Visionary BioScience) for RNA collection or FACSAria (BD
Biosciences, San Jose, CA) for cell culture experiments. Dead cells and debris were first
excluded based on size via bivariate plot of forward scatter (FSC) vs. side scatter (SSC)
(Supplemental Figure 3A). Doublets/multimers were excluded using a bivariate plot of FSC
peak vs. FSC length (Supplemental Figure 3B). Epithelial cells were FACS-enriched by
sorting EpCAM (CD326) positive, CD45 negative cells (Supplemental Figure 3C). The
remaining cell events were analyzed for CD24 and CD44 expression on a bivariate plot
(Supplemental Figure 3D). Five cell populations: CD45−EpCAM+(whole), CD45−EpCAM
+CD24−CD44− (negative), CD45−EpCAM+CD24+CD44− (CD24+CD44−),
CD45−EpCAM+CD24−CD44+(CD24−CD44+), CD45−EpCAM+CD24+CD44+
(CD24+CD44+) were collected directly into 500 μl of RNA lysis buffer (Ambion
RNAqueous Micro, Grand Island, NY) for gene expression analysis. For cell culture
experiments, cells were collected into 500μL of IESC Staining Media.
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Primary isolation of human small intestinal myofibroblasts
Following mucosectomy for epithelial prep, remnant submucosa (~4cm × 4cm) was diced
with a sterile razor blade. To eliminate blood cells and remnant epithelium, tissue chunks
were washed in 20mL DMEM (Gibco), shaken for 2 minutes, and then allowed to settle
before supernatant was removed and discarded. This process was repeated 8 times. The
submucosal tissue was then resuspended in 5mL DMEM containing Penicillin/
Streptomycin, 0.3U/mL dispase, and 300U/mL collagenase I (Sigma) and rotated for 25 min
at room temperature. 10mL of DMEM +10%FBS was added to quench the reaction and the
tissue suspension was pipetted vigorously ~50 times to further mechanically dissociate
myofibroblasts. The tissue suspension was centrifuged at 300g for 5min and the resulting
supernatant and tissue remnants were plated separately in DMEM +10%FBS. Media was
changed every 24hrs. Cultures initiated from the supernatant of the prep produced
myofibroblasts, which were passaged 3 times before use in IESC culture experiments.
Intestinal epithelial stem cell culture
Cells were pelleted and resuspended in ES-qualified Matrigel (BD Biosciences) containing
IESC culture growth factors (see Supplemental Table 2). For feeder-free cultures, 10μL
Matrigel droplets were plated in 96-well plates and overlaid with 100μL IESC Sort/Culture
Media, with or without 2.5μM CHIR99021 (Selleck Chemical) following 15 minute of
polymerization at 37°C. For feeder co-culture, 25μL Matrigel droplets were allowed to
polymerize in 12-well transwell inserts (BD Biosciences) before being placed in wells
containing fibroblast feeder cells and 500μL IESC Sort/Culture Media. An additional 500μL
of the same media was placed in the transwell to prevent drying of the Matrigel droplet.
CHIR99021 was not used in co-culture experiments. To facilitate differentiation of
enteroids, Wnt3a, SB202190, and nicotinamide were withdrawn at 14 days of culture, as
previously described for whole crypt cultures11.
cDNA preparation/real-time PCR analysis
mRNA from sorted cell populations was purified by using RNAqueous Micro Kit (Ambion)
according to the manufacturer’s protocols. cDNA was generated using iTaq Reverse
Transcription Supermix (Bio-Rad, Hercules, CA). Real-time PCR was conducted for each
sample in triplicate on 1/20,000 of the total amount of cDNA generated. Taqman probes
[18S, HS99999901; CD24 Hs00273561_s1; CD44, Hs01075861_m1; LGR5
Hs00173664_m1; OLFM4 HS00197437_m1; HOPX Hs04188695_m1; DEFA6
Hs00427001_m1; LYZ Hs00426232; MUC2 Hs00159374_m1; CHGA Hs00900373_m1]
for each gene were obtained from Applied Biosystems (Pleasanton, CA) and used in
reactions according to the manufacturer’s protocol.
Statistical Analysis
qRT-PCR data was normalized for the expression of 18S. ΔΔCt values were then calculated
using the CD24−CD44− (negative) cell population as the comparator. Statistical analysis
compared gene expression across all cell populations by gene for each patient via one-way
ANOVA followed by Bonferroni post-test for multiple comparisons between the population
of interest and all other populations. Statistical analysis was performed in Graph Pad Prism
(ver 4.0, LaJolla, CA).
Results and discussion
CD24 and CD44 expression was assessed on human jejunum derived from patients who had
undergone roux-en-y gastric-bypass surgery. Immunostaining demonstrates that CD44 is
expressed on cells from the base of the crypt to the crypt-villus junction (Figure 1A, C, &
E). By contrast, the villus epithelium does not show appreciable CD44 staining (Figure 1B
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& D). CD24 demonstrates similar expression to CD44 in the epithelium with the notable
exception that staining is primarily distributed along the apical membrane (Figure 1F & H,
arrows). A minority population of crypt-based cells expresses high levels of cytoplasmic
CD24 (Figure 1G & I, arrows). While CD24/44 expression is highly restricted to the stem
cell zone in the epithelium, there is broad expression in non-epithelial cells in the lamina
propria, sub-mucosa, and muscle (Figure 1A–I). EpCAM (CD326) expression is unique to
all crypt and villus epithelial cells, and was deemed useful for positive FACS selection to
separate epithelial from non-epithelial CD24/44-expressing cells (Figure 1J–L).
Next, we analyzed CD24, CD44, CD45, and CD326 on dissociated single epithelial cells
(Supplemental Figure 2). Positive selection for epithelial cells (EpCAM+) and negative
selection for lymphocytes (CD45−) was included in the FACS parameters for robust
epithelial enrichment (Supplemental Figure 3C). Flow cytometry data demonstrate four
distinct epithelial cell populations based on CD24/44 expression status (Supplemental
Figure 3D). Each of the four populations (CD24−/44−; CD24+/44−; CD24−/44+; CD24+/
44+) was collected for gene expression analysis. Semi-quantitative reverse transcriptase
polymerase chain reaction (qRT-PCR) validated the FACS by showing enriched gene
expression for CD24/44 in the appropriate populations (Supplemental Figure 4A & B). The
data demonstrate that CD24−/CD44+ populations are most enriched for the “active” cycling
IESC markers, LGR5 and OLFM4 (Figure 2A & B); and the CD24+/CD44+ population is
most enriched for the “reserve/facultative” IESC marker HOPX (Figure 2C). Interestingly,
all CD24+ and CD44+ populations demonstrate significant de-enrichment for Paneth cell
markers DefensinA6 (DEFA6) (Supplemental Figure 5A) and Lysozyme (LYZ)
(Supplemental Figure 5B), and goblet cell marker, Mucin2 (MUC2) (Supplemental Figure
5C), all of which associate with CD24 expression in mice 7, 12, 13. However, the CD24+/
CD44+ population is highly enriched for the enteroendocrine cell marker Chromogranin A
(CHGA) which is consistent with observations made in mice (Supplemental Figure 5D) 10.
To test if the CD24−/CD44+ and CD24+/CD44+ populations had functional properties of
stemness, we subjected isolated single cells to culture conditions similar to those that have
been successfully used to grow small intestine crypts and single colonic stem cells from
human tissue 11, 14. Both IESC populations formed appreciable cystic enterosphere
structures by 48hrs (Figure 3A), while the other populations (CD24−/CD44− and CD24+/
CD44−) failed to do so. Enterospheres derived from CD24−/CD44+ cells continued to
develop over the first week of culture, while CD24+/CD44+ derived enterospheres exhibited
a limited increase in size (Figure 3A). Nevertheless, both populations persisted in culture at
7 days (Figure 3B & C). In an attempt to increase culture efficiency, we added GSK-
inhibitor CHIR99021, which promotes self-renewal of embryonic stem cells was recently
used to enhance in vitro growth and survival of human colon cancer stem cells and intestinal
crypts (Wang, et al unpublished) 15, 16. Interestingly, initial GSK-inhibition significantly
improved 7-day enterosphere survival in the CD24−/CD44+ population, but had no
appreciable effect on the CD24+/CD44+ population (Figure 3B & C). Initial GSK-inhibition
greatly increased 14-day survival of the CD24−/CD44+ population, but was insufficient for
the maintenance of CD24+/CD44+ derived enteroids, which did not survive to 14 days,
regardless of GSK-inhibition (Figure 3C). Previous studies have shown that Lgr5-negative
populations can de-differentiate and function as “facultative” stem cells when presented with
the proper extrinsic cues 7, 8. Additionally, co-culture of primary human intestinal crypts
with myofibroblasts enhances culture efficiency 17. In an attempt to “activate” the CD24+/
CD44+ population, we co-cultured the cells with myofibroblasts isolated from human
jejunal submucosa. Surprisingly, when grown in these conditions, both CD24−/CD44+ and
CD24+/CD44+ cells produced long-lived enteroids, at rates of 0.07% and 0.76%,
respectively (Supplemental Figure 6).
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To assess multipotency, we retrieved and processed enteroids for immunohistochemistry at
21 days. CD24−/CD44+ derived enteroids were epithelial in nature (Supplemental Figure 7)
and produced enteroendocrine (CHGA), goblet (MUC2), and Paneth cells (LYZ), as well as
absorptive enterocytes (SIM) (Figure 4B). CD24+/CD44+ cells grown in co-culture with
primary human myofibroblasts exhibited the same characteristics of multipotency as
CD24−/CD44+ cells (Figure 4C and Supplemental Figure 7). Enteroids derived from both
populations exhibited increased numbers of lysozyme positive cells, consistent with results
in mice demonstrating that persistent WNT signaling, specifically through CHIR99021
treatment, increases Paneth cell production in enteroid culture 18. This biased secretory
lineage allocation likely explains the rare occurrence of MUC2 positive cells in the
enteroids. Importantly, co-culture with myofibroblasts did not induce growth in CD24−/
CD44− and CD24+/CD44− populations, demonstrating that functional stemness under all
tested growth conditions remains restricted to CD24−/CD44+ and CD24+/CD44+
populations.
The translation of scientific findings made in genetically homogeneous mouse models
presents investigators with a daunting challenge when attempting to understand the vast
heterogeneity underlying physiology in human populations. This report provides new
methodology for epithelial dissociation, isolation, and FACS enrichment of IESCs from
human small intestine through the use of a combinatorial CD-marker “signature”. The
ability of CD24 and CD44 to enrich for IESCs is highly consistent with observations in
mice; however, in stark contrast to findings in mouse models, human Paneth cells do not
appear to express high levels of CD24, highlighting the need to validate mouse genetic
biomarkers on human samples 7, 10, 12, 13. Furthermore, our results demonstrate variable
levels of gene enrichment between some patients. This observation could be attributed to a
wide range of factors, including phenotypic heterogeneity between samples. In the present
study, tissue procurement protocols required full de-identification of samples; thus, a
patient’s dietary habits, state of illness, or medication history could not be correlated to gene
expression variations. This highlights the need for comprehensive studies with controlled
enrollment criteria, utilizing the foundation for isolation of LGR5 and HOPX-enriched
populations, presented here
In addition to FACS-enrichment of ‘active’ LGR5+ IESCs, the CD24/CD44 approach
facilitates differential isolation of HOPX+ cells, which emerging evidence suggests may
represent facultative IESCs 4. While several of the markers examined here exhibit a degree
of variability between samples, it is clear that the population of cells most enriched for
LGR5 is distinct from the population most enriched for HOPX, unlike recent observations of
Hopx expression in murine Lgr5+ cells 6. Additionally, CD24−/CD44+ and CD24+/CD44+
populations exhibit differential behavior in vitro, both in response to GSK-inhibition and in
basal culture conditions required for growth, further supporting the existence of
phenotypically distinct IESC populations. Though overlap of LGR5 expression with putative
“reserve” IESC markers in mice remains controversial, our data suggests that more distinct
populations may exist in the human small intestinal epithelium 4–6, 19. Further work is
needed to characterize the CD24+/CD44+ population and determine if it is analogous to
proposed “facultative” IESCs observed in mouse models of intestinal damage and
regeneration. Multiple reports have demonstrated the ability of Lgr5-negative facultative
IESCs to drive regeneration in murine intestine following irradiation, suggesting that an
analogous population may be of particular interest in human pathophysiology, especially in
patients undergoing radiation treatment for tumors 7, 8. Understanding the genetics and
patient-to-patient heterogeneity of phenotypically distinct human IESC populations may
provide valuable insight toward the development of novel clinical diagnostics and
therapeutic interventions.
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Figure 1. CD24 and CD44 are expressed in the stem cell zone of the human intestinal epithelium
Epithelial expression of CD44 is restricted to the basolateral membranes of crypt cells (A, C,
& E), with no expression in villus epithelium (B & D). CD24 is also restricted to the crypt,
but is expressed on the apical membrane of epithelial cells (F & H, arrow). A subset of
crypt-based epithelial cells expresses high levels of cytoplasmic CD24 (G & I, arrows).
CD326 (EpCAM) is expressed throughout both the crypt and villus, but remains restricted to
epithelial cells (J–L). Scale bars represent 50μm.
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Figure 2. CD24−/CD44+ and CD24+/CD44+ intestinal epithelial cells are enriched for active and
reserve/facultative markers, respectively
CD24−/CD44+ cells are significantly enriched for active IESC markers (A) LGR5 and (B)
OLFM4, while CD24+/CD44+ cells exhibit enrichment for (C) HOPX, which is associated
with reserve/facultative IESCs. Letters a–d above each bar indicate data points that are
statistically different from each other (p < 0.05).
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Figure 3. CD24−/CD44+ and CD24+/CD44+ populations generate enteroids in vitro
By 48hrs, CD24−/CD44+ and CD24+/CD44+ cells form small enteroid structures, which
increase in size over the first week of culture (A). GSK inhibition through a single dose of
CHIR99021, given when cells are plated, significantly increases 7- and 14-day survival of
enteroids derived from CD24−/CD44+ cells (B), but has no noticeable effect on the CD24+/
CD44+ population (C). While CD24−/CD44+ cells form long-lived enteroids, the CD24+/
CD44+ population does not demonstrate survival at or after 14 days in culture in feeder-free
conditions (A). Student’s t test was used to determine significance. Asterisks indicate a P-
value of < 0.01. Scale bars represent 100μm.
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Figure 4. Enteroids derived from CD24−/CD44+ and CD24+/CD44+ populations are multipotent
Enteroendocrine, goblet, and Paneth cells, as well as absorptive enterocytes, are detectable
in whole human jejunum by expression of CHGA, MUC2, LYZ, and SIM, respectively (A).
Similar expression patterns for each marker are observed by immunofluorescence in
enteroids derived from the LGR5-associated CD24−/CD44+ population (B) and the HOPX-
associated CD24+/CD44+ population (C). Arrows indicate positive staining, asterisks mark
enteroid lumens, and dotted lines denote outer edge of enteroid structures. Scale bars
represent 50μm.
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